Marcus Evans is proud to announce the Evolution Summit 2025, an exclusive, invitation-only event that will unite leading clinical trial executives with innovative suppliers and solution providers in ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Serge Belanger has given his Buy rating due to a combination of factors surrounding Trevi Therapeutics’ recent ...
iTeos Therapeutics (ITOS) announced the presentation of clinical, translational, and preclinical data from its adenosine A2A receptor antagonist program, inupadenant, including interim data from the ...